Literature DB >> 29450685

Reducing Long-term Opioid Use in the Veterans Health Administration.

Taeko Minegishi1,2,3, Austin Frakt4,5,6.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29450685      PMCID： PMC5975154          DOI： 10.1007/s11606-018-4352-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  9 in total

1.  Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan.

Authors:  Karen H Seal; Ying Shi; Gregory Cohen; Beth E Cohen; Shira Maguen; Erin E Krebs; Thomas C Neylan
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

2.  Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness.

Authors:  Taeko Minegishi; Austin B Frakt; Melissa M Garrido; Walid F Gellad; Leslie R M Hausmann; Eleanor T Lewis; Steven D Pizer; Jodie A Trafton; Elizabeth M Oliva
Journal:  Subst Abus       Date:  2019-01-08       Impact factor: 3.716

3.  Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs.

Authors:  Walid F Gellad; Chester B Good; David J Shulkin
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

4.  Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011.

Authors:  Mark J Edlund; Mark A Austen; Mark D Sullivan; Bradley C Martin; James S Williams; John C Fortney; Teresa J Hudson
Journal:  Pain       Date:  2014-08-29       Impact factor: 6.961

5.  Do patient-perceived pros and cons of opioids predict sustained higher-dose use?

Authors:  Stephen M Thielke; Judith A Turner; Susan M Shortreed; Kathleen Saunders; Linda Leresche; Cynthia I Campbell; Constance C Weisner; Michael V Korff
Journal:  Clin J Pain       Date:  2014-02       Impact factor: 3.442

Review 6.  Advancing the Pain Agenda in the Veteran Population.

Authors:  Rollin M Gallagher
Journal:  Anesthesiol Clin       Date:  2016-06

7.  Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016.

Authors:  Katherine Hadlandsmyth; Hilary Mosher; Mark W Vander Weg; Brian C Lund
Journal:  J Gen Intern Med       Date:  2018-01-29       Impact factor: 5.128

Review 8.  Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.

Authors:  Joseph W Frank; Travis I Lovejoy; William C Becker; Benjamin J Morasco; Christopher J Koenig; Lilian Hoffecker; Hannah R Dischinger; Steven K Dobscha; Erin E Krebs
Journal:  Ann Intern Med       Date:  2017-07-11       Impact factor: 25.391

9.  Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design.

Authors:  Taeko Minegishi; Melissa M Garrido; Steven D Pizer; Austin B Frakt
Journal:  BMJ Open       Date:  2018-06-27       Impact factor: 2.692
  9 in total
  3 in total

1.  Opioid Discontinuation Among Patients Receiving High-Dose Long-Term Opioid Therapy in the Veterans Health Administration.

Authors:  Taeko Minegishi; Melissa M Garrido; Michael Stein; Elizabeth M Oliva; Austin B Frakt
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

2.  Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans.

Authors:  Patience Moyo; Xinhua Zhao; Carolyn T Thorpe; Joshua M Thorpe; Florentina E Sileanu; John P Cashy; Jennifer A Hale; Maria K Mor; Thomas R Radomski; Julie M Donohue; Leslie R M Hausmann; Joseph T Hanlon; Chester B Good; Michael J Fine; Walid F Gellad
Journal:  Res Social Adm Pharm       Date:  2018-10-17

3.  Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans.

Authors:  Corey J Hayes; Laura E Gressler; Bo Hu; Bobby L Jones; J Silas Williams; Bradley C Martin
Journal:  J Pain Res       Date:  2021-06-14       Impact factor: 3.133
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.